One of the key problems that have faced the treatment of cancer over the years is the extreme side effects caused by the main line treatments. The triad of radiation, chemotherapy and surgery have been the mainstay of cancer treatment since the 1950s. However, all of those treatments come with horrendous side-effects, up to and including the death of the patient. These terrible adverse outcomes have long been a primary motivating factor in the quest to seek new modes of cancer treatment that retain or even improve upon the overall effectiveness of the older methods while reducing or completely eliminating the side effects that come with them.
The area of cancer research that sprung up in the late 1980s, referred to as targeted cancer therapies, includes a wide range of completely disparate treatments. Some of these involve the modification of genetics. Others involve mechanical treatments that make use of nanoscopic-level precision, such as the use of automated laser systems to excise malignant tissue.
But one method of targeted cancer therapy that has proven to be both effective and highly innovative is the use of antibody drug conjugates. This class of drugs was developed by a man named Clay Siegall and his team at Bristol-Myers Squibb in the mid-90s. Using antibodies derived from real humans, which are often synthetically produced in the laboratory, antibody drug conjugates bind a cytotoxin to the anti body itself, only allowing for the release of the highly lethal chemical when it has actually come into contact with the tumor site.
In theory, this method of delivering chemotherapeutic agents can eliminate completely the horrible side effects that come with mass systemic release of poison into the bloodstream. In practice, it is always a bit more complicated. However, antibody drug conjugates that have been approved for use in the general public have indeed proven that it is possible to radically reduce the side effects that are associated with traditional chemotherapy.
Dr. Siegall, through his company, Seattle Genetics, is currently producing the only FDA-approved antibody drug conjugate. It has been approved for use in refractory non-Hodgkin’s lymphoma and is marketed under the brand name ADCetris. This drug has saved thousands of lives each year and holds the promise of being approved by the FDA for many other treatments.
If things continue on the same course for Seattle Genetics, within a decade, Dr. Siegall may be the most famous name in the pharmaceutical industry.
Although Amicus Therapeutics is located in New Jersey, the biopharmaceutical company is making huge strides around the globe. The company’s focus is on treating a wide range of devastating rare and orphan diseases. These diseases include Pompe Disease, Fabry Disease, and other Lysosomal Storage Disorders(LCDs) (Indeed). The company has an ongoing product pipeline that addresses the needs of those suffering from these diseases.
Amicus Therapeutics scientists dedicate their time and research to finding treatment for rare and orphan diseases through innovation and technology. These groundbreaking findings allow for patients to benefit from the enhanced treatments that the research uncovers.
The company has goals for those working within the company and for those that the company hopes to wish through its work. Amicus Therapeutics believes in the continuous growth of ideas to remain at the forefront of learning more about rare diseases. The company takes smart risks to ensure that they are doing everything possible on behalf of those suffering from these rare diseases. The company supports the patients and the families of those affected by giving them hope and education. The company believes in being honest and ethical to provide long lasting partnerships with other companies. Producing medicines that are reasonably priced and easily obtainable is important to Amicus Therapeutics.
Amicus Therapeutics has teamed with patient organizations, families, and healthcare providers to ensure that the company is doing all that is possible to positively advocate for those in need. Because the diseases are so rare that Amicus Therapeutics works to treat, it is essential that the company reaches out to all in need of help. Today, the company is continuing its work, by developing treatments and introducing new ideas on how to help those in need of the research and medicines that have been discovered. The company promises also to continue to educate about these rare and orphan diseases so that others can help in the fight to advocate on behalf of those in need.
More about Amicus Therapeutics https://twitter.com/amicusrx1?lang=en
Arthritis is a common disorder that causes swelling of the joints. There are dozens of different types of arthritis, but the most common by far is osteoarthritis. Osteo Relief Institute dedicates itself to treating these patients.
Osteoarthritis occurs when the cartilage around the joints begins to degenerate or break down. This can happen due to advancing age, sports injuries, excessive weight, and genetics. When the cartilage wears down enough, this supportive tissue around the joints allows the bones to rub one another at the joint junction. It is this rubbing that causes swelling and pain ranging from mild to severe. Osteo Relief Institute has an excellent team of specialists that include board certified orthopedists and physical therapists specially trained in orthopedic therapy.
Conservative treatments such as weight loss, exercises, and walking can help lessen the stiffening caused by osteoarthritis. There are times, of course, when surgical intervention is necessary when other treatments fail or run their course. Minimally invasive and laparoscopic surgeries are far less debilitating than full joint replacements.
The team at Osteo Relief Institute understands the pain their patients suffer with on a daily basis. Their compassionate care is one of the reasons their patients seek them out, treating patients as though they’re family. There is no cure for osteoarthritis but there are treatments to help with the pain. There are over the counter drugs known as NSAIDs or nonsteroidal anti-inflammatory drugs (CrunchBase). This class of drugs includes aspirin, ibuprofen, and naproxen. There are also prescription pain medications that are anti-inflammatory or opioids to name a few.
The physicians at Osteo Relief Institute have dedicated themselves to helping those suffering from osteoarthritis without using strong pain medications which can cause dependence, or NSAIDs, which can be irritating to the stomach.
This type of arthritis is commonly seen in the larger joints such as the knee, spine, and hip. These joints, in particular, are under considerable stress by harnessing a burden of the body’s weight. The compassionate staff at the Osteo Relief Institute has the latest equipment and FDA approved techniques to treat this osteoarthritis pain without surgery.
Find a location near you at http://www.edgewaterosteoreliefinstitute.com/
Beer is Canada’s most popular alcoholic drink. And craft beer is at the top of the list. While beer consumption has dropped slightly overall, craft beer sales and consumption have continued to rise. In fact, sales of craft beer in Canada have averaged double digit growth every year since 2009. There are a growing number of breweries all across Canada that produce excellent, flavorful, traditional and unique craft beers to meet the growing demand. One example of how much Canadians love craft beer is Niagara College created the country’s first teaching brewery and a post-secondary brewmaster program.
Canada’s love for craft beer has grown so much that many of the microbreweries that produce them no longer qualify to be called micro-breweries. In Ontario, craft beer breweries that produce 400,000 or more hectolitres of beer annually are not classified as micro-breweries. And a quite a few former micro-breweries fall into that category. One Quebec based brewer of craft beer reportedly averages over $20 million a year in sales.
Eli Gershkovitch, the owner, and CEO of the Canadian company Steamworks craft breweries is one person that has seen the growth in the Canadian craft beer industry up close. He was inspired to open a craft brewery after a 1987 tour of several European brewing establishments. Not long afterward he founded a small brew pub called Steamworks. Eli Gershkovitch is now an industry veteran. He has been brewing craft beer for over 20 years and has slowly grown his company. To maintain control of the rate of growth of Steamworks, Eli Gershkovitch bought out his partner in 1997. (http://www.calgaryherald.com/Steamworks+owner+Gershkovitch+awarded+registered+trademark+Cascadia+2006+after+seven+year+dispute+with+Granville+Island+Brewing/7612614/story.html)
In 2013 Eli Gershkovitch made his boldest business move. He expanded to a full-scale brewery. His brewery now produces over 40,000-hectolitre of craft beer. Eli Gershkovitch is no longer simply a brew pub owner with a 2,000-hectolitre output. He is now an internationally-known craft brewery pioneer. His Steamworks brand craft beer has a growing customer base in a number of Canadian provinces, as well as in 14 of the United States. Eli Gershkovitch also has international customers in Austria, Germany, Hong Kong, Italy, and Switzerland.
Glen Wakeman, CEO, and Co-founder of LaunchPad Holdings, LLC, is mainly known as a successful mentor and entrepreneur. Wakeman has achieved great fleets all throughout his lifetime and business career. He is praised for his great works in the fields of management and commerce. Glen Wakeman’s life of tremendous success has advanced and influenced industries concerning global affairs and markets.
Wakeman has put his time and energy in becoming educated in contemporary commerce. He first graduated from the University of Scranton in 1981 with a Bachelor’s Degree in Economics and Finance. In 1993, Glen Wakeman received a Master of Business Administration in the field of Finance from the University of Chicago.
After spending his spirit and vigor in getting degrees concerning the modern market, Glen Wakeman decided he would start his career with a boom. He was offered a job at GE Capital that pertained to profit and loss and business development. After GE Capital, he moved on through the ranks at the Doral Financial Corporation, becoming the company’s CEO and President.
Soon, Wakeman also began his mentoring career. He has guided very large businesses throughout his life. Many of them contain very large numbers of staff and tremendous budgets (Ideamensch). Glen Wakeman’s experience and hard work led to the great success of many of the businesses he worked with. His principles and background were utilized in many different types of firms and organizations.
Glen Wakeman is also known for his educational and informing blogs, each updated on a regular basis. His blogs concern topics such as the current market and what it may become, leadership, and financing. Wakeman’s blogs provide the tips that he follows when he concerns himself with commerce. His passion for marketing and finance inspire him to also share his ideas and opinions with others from all around the world.
More about Glen Wakeman at https://en.wikipedia.org/wiki/Doral_Financial_Corporation
In New Orleans the Texas Bankers Association held their 5th annual Strategic Opportunities and M&A Conference. This took place in November of 2016, Mr. Holt the President and CEO of NexBank was a panelist. NexBank Capital Inc is a financial services company. The company serves its clients through 3 core businesses. The core businesses are, Commercial Banking, Mortgage Banking, and Industrial Services.
NexBank was established in 1934, with it’s headquarters located in Dallas, Texas. As of March 2017 they have 86 employees at 4 locations. They are the 4th largest bank in Texas and the 200th in the nation. The directors of NexBank bring a wide range of management and leadership experience. The director’s also have a strong commitment to the company’s success. Their clients are mostly institutional clients and financial institution. They also serve corporations, real estate investors, and middle-market companies. There are specific services available under the 3 blanket services. Under the Commercial banking services, you have the choice of 6 options that fit needs your need best. Under the Mortgage Banking services, you have a choice of 3 options depending on your needs. Under the Institutional services there are 5 different options you can find services through.
Richard Mishaan is a fashionista, stylist, architect and interior designer based in New York. His love for style and interior design plus his cultural roots gives him an earnest understanding of luxury and quality. He has a BA from New York University and another degree in Architecture from Columbia University School of Architecture. He started his career in design working as an intern at the offices of Phillip Johnson.
He is the founder of Richard Mishaan Design, a leading company in interior design. The company has been offering extra ordinary designs for the last 25 years for hospitality, residential and commercial clients. The company constantly featured in the Elle Décor A List and AD 100. It has produced among the best interior designs for various big clients in hotel, residential and retail projects around the world.
The success of Richard Mishaan Design is based on Richard Mishaan’s efforts to create synergies between different pieces whose common bond is tonality. Mr. Richard says that he purposes to create elegant designs that induce the excitement of his customers. While starting out, Richard worked on various high-end projects. He decided to put the experience he gained into use by opening his firm, Richard Mishaan Design. Due to the great reputation, he had developed over the years made his name a household brand respected by many.
Richard Mishaan Design has a team of experienced and knowledgeable interior designers who ensure that they constantly make designs that surpass their customer expectations. The company’s designs go beyond the 21st Century. Some of its designs are enthused by ancient artwork which they then blend into modern art to create luxury designs.
Some of the notable works by Richard Mishaan Design include Richard’s own home in Cartagena which was 16th Century house which was upgraded by the firm to include a stylish roof deck and a Stunning courtyard. Others include; Shelborne Wyndham Grand South Beach, Josh Alexander’s loft,
Richard Mishaan is also an author. He has authored two books for the Monacelli Press, Artfully Modern and Modern Luxury. He is also the owner of Homer Design, a furniture shop situated in Greenwich Village which sells a wide variety of contemporary and vintage items.
Talk Fusion has become the golden standard for video marketing and communication solutions on the digital platform. If you run a business nowadays you are, at some point, going to need the kind of services that this company offers. Thankfully for us the CEO and founder of Talk Fusion came up with his ideas and got them rolling over a decade ago. Bob Reina is the ambitious, candid, and open founder of Talk Fusion and he has been the guiding force that has put the wind in the sails of the company. Talk Fusion just finished off a great 2016 which concluded with various industry awards. Now, Reina looks to the past to see how he got to this point. Learn more: http://yourmarkontheworld.com/talk-fusion-founder-ceo-bob-reinas-mission-change-lives/
Bob Reina used to work as a police officer, nearly 15years ago at this point. While working as a police officer, for a full decade in fact, Becker got used to the idea of being another part of the structured machine. But he always wanted a chance to step out and show the world that he could be his own boss and create something that would be of value to people. After talking to a network marketing executive during an off-duty security gig, Reina had his answer. While the seeds of Talk Fusion were planted in 2003 or so, they wouldn’t actually begin to grow into fruition until nearly 2007. Learn more: https://www.businessforhome.org/2011/11/bob-reina-ceo-talk-fusion-interview/
Talk Fusion launched around Bob Reina’s favorite product: the Video Email marketing suite. Reina was so excited and passionate about his flagship program that he talked it up to every business he could think of. The results were great. By the time Talk Fusion was launched there was already a generous buzz and people who wanted to get involved with Talk Fusion. Reina even admits that they were profitable pretty much from day one.
The key to Reina’s continued success lay in that same passion. Reina believes in the power of video and fundamentally believes that you need it in order to succeed. He loves his products and takes pride in helping out other businesses. This joy will keep Talk Fusion growing for years to come. Learn more: https://www.youtube.com/watch?v=73t_xeZFmIQ
Richard Shinto is InnovaCare, Inc.’s current President and CEO. He used to operate another company, Aveta Inc. but dedicated himself to InnovaCare Health after Aveta’s sale in 2012. Since then, he’s played a huge role in much of InnovaCare’s current success. He leads InnovaCare’s entire team of qualified leaders.Shortly after joining the company, Dr. Richard Shinto began heading up the company’s Puerto Rican subsidiary health plans company. It wasn’t long after that InnovaCare earned the rank of number one managed care provider in Puerto Rico. Subsequently, Dr. Shinto was named CEO of InnovaCare’s Health Plans subsidiary in that country.
Before joining Aveta, Dr. Shinto worked at NAMM California as their Chief Medical Officer. By that time, he’d amassed years of experience in his field working at companies like Medical Pathways Management Company Cal Optima Health Plan. Most of the positions he held at those companies were as Medical Officer.Even before joining the managed care industry, Dr. Shinto was an accomplished young man. To this day, he maintains his medical tenure in Southern California. There, he’s a practicing internist and pulmonologist. He’s also written articles about clinical medicine, most of which earned him his respected reputation.Since the company’s founding, its sole mission has been to redefine healthcare management. It’s element to living healthy that many people overlook until it’s too late. By then, they’re overwhelmed by all the technical terms and outrageous expenses.
InnovaCare Health is a top provider of managed care because of its friendly atmosphere. InnovaCare believes in putting patients first. They’re focused on building patient-provider relationships so that they can better take care of their patients; thereby, increasing the number of healthier outcomes and betting the quality of life for every patient they help.It seems like every managed care professional has their own unique talents. Perhaps one of the most talented professionals in the entire industry is InnovaCare’s newest Chief Administrative Officer, Penelope Kokkinides. Penelope Kokkinides has over 20 years experience in the industry and specializes in working with government programs.Much of her work revolves around reconstructing a company’s strategic development to maximize the chance of goal-oriented success. Many of the health care operations she introduces improve company efficiencies and organizational infrastructure. She also has extensive knowledge on developing clinical programs.
Reaching out to Amicus Therapeutics
Whenever you are looking to get the most out of your biotechnology and medical care, it is important contact the highest quality professionals in the field. This is particularly crucial if you happen to be dealing with a disease that is rare or that you have not gotten properly diagnosed yet. By taking advantage of the services offered by Amicus Therapeutics, you will learn more information about this company and the programs that they have in place. If you are interested in more information on Amicus Therapeutics, use the tips below so that you can get help.
Who is Amicus Therapeutics?
This is a company that has provided global biotechnology for years (Google Finance). They deal with a lot of different genetic diseases, which require advancements in technology in order to continuously catch up. This company takes the needs of people who suffer from rare diseases seriously and continuously does what they can to push the industry forward. As a result, few medical professionals make as meaningful and impact in the lives of their patients as Amicus Therapeutics. This is a company that was founded in the year 2002 and is currently headquartered in Cranbury, New Jersey. They have upwards of 500 employees throughout the company and are publicly traded.
Amicus Therapeutics uses its resources in order to provide personal medical therapies to people who require this aspect of service. This is so crucial, because people who have rare diseases often struggle to get proper diagnoses and to get the best medical care available. You will be able to take full advantage of a lot of different genetic ailments – to include epidermolysis bullosa, Fabry disease and Pompe disease.
There are a lot of success stories rooted to this company due to the fact that they have saved a lot of lives by giving people accurate diagnoses and treatments. Their work is second to none in this regard and is a big reason why technology has grown by leaps and bounds throughout the medical industry. They strive to continuously give patients life-changing care every step of the process.
More here: Twitter | Facebook | Chrunchbase